Research article | Open | Open Peer Review | Published:
Measuring access to effective care among elderly medicare enrollees in managed and fee-for-service care: a retrospective cohort study
BMC Health Services Researchvolume 1, Article number: 11 (2001)
Our aim was to compare access to effective care among elderly Medicare patients in a Staff Model and Group Model HMO and in Fee-for-Service (FFS) care.
We used a retrospective cohort study design, using claims and automated medical record data to compare achievement on quality indicators for elderly Medicare recipients. Secondary data were collected from 1) HMO data sets and 2) Medicare claims files for the time period 1994–95. All subjects were Medicare enrollees in a defined area of New England: those enrolled in two divisions of a managed care plan with different physician payment arrangements: a staff model, and a group model; and the Medicare FFS population. We abstracted information on indicators covering several domains: preventive, diagnosis-specific, and chronic disease care.
On the indicators we created and tested, access in the single managed care plan under study was comparable to or better than FFS care in the same geographic region. Percent of Medicare recipients with breast cancer screening was 36 percentage points higher in the staff model versus FFS (95% confidence interval 34–38 percentage points). Follow up after hospitalization for myocardial infarction was 20 percentage points higher in the group model than in FFS (95% confidence interval 14–26 percentage points).
According to indicators developed for use in both claims and automated medical record data, access to care for elderly Medicare beneficiaries in one large managed care organization was as good as or better than that in FFS care in the same geographic area.
Over 32 million elderly Americans are enrolled in the Medicare health insurance program. Since 1982, the Health Care Financing Administration has offered a managed care option, with capitated payment, to Medicare enrollees. Currently nearly 15% of Medicare enrollees are members of managed care plans nationwide. 
The economic incentives of capitated payment have raised concerns that managed care organizations that use capitation might limit provision of effective services as a way of trimming costs. [2–5] Public concerns about restriction of service in managed care organizations have led to proposed legislation for a "patient's bill of rights." once again being considered in the US Senate.  It is becoming clear, however, that "managed care" is not a single entity, and that a wide range of economic incentives and disincentives may be created in various forms of managed care,  each likely to have different kinds of influence on clinician behavior. [9–11] The proximity of risk to the clinician or clinician group has an especially strong effect on behavior.  Systems maintained by managed care organizations to assist clinicians in providing quality care also differ widely, and may strongly influence performance.
Although reduced access to care is a theoretical risk of capitated payment, relatively few studies have addressed whether this concern is borne out in practice. Perhaps because of the variation in managed care arrangements, the results of studies have been mixed.  If managed care presents barriers to access to effective care, the elderly would be especially vulnerable because they have a higher burden of illness than the rest of the population. We therefore created indicators in several domains for which it was known that care improved outcomes. We then used these indicators to compare health care received by elderly Medicare beneficiaries in three kinds of payment arrangements: a capitated, staff-model health maintenance organization (HMO) and a partially capitated group-model HMO, both parts of the same managed care organization, and in fee-for-service (FFS) care in the same geographic area.
The managed care plan participating in this study, Harvard Pilgrim Health Care (HPHC), is the largest HMO in New England, and is a not-for profit entity. It was begun in 1981 as Harvard Community Health Plan, a Staff Model HMO that at the time of this study comprised about 300,000 members at fourteen health centers in the greater Boston area. Harvard Pilgrim Health Care had grown by merger to include, among its divisions, one made up of non-exclusive medical groups; at the time of this study the Group Model HMO cared for about 186,000 members in eastern Massachusetts.
For both divisions, the Medicare enrollees eligible for this study included all those age 65 and older who were members for part or all of the period January 1, 1994 through December 31, 1995. Almost 10,000 members from the Staff Model and 5,000 in the Group Model met these criteria. Members who switched from one division to the other during the study period (497 members, 2 percent of the combined samples) were not included in the study. Samples were defined separately for each indicator (see Tables and Additional file Indicator Definitions).
Staff model HMO
The Staff Model division of HPHC provided primary care-based, multi-specialty care. The organization has cared for aged Medicare patients in risk and other commercial plans since the mid-1980's. All primary care providers were salaried and there were no specific economic incentives (i.e. no bonuses of any kind) for individual providers during the study period.
Information on all ambulatory services, including visits, diagnoses, procedures and tests, was maintained electronically for all members as part of an Automated Medical Record System (AMRS.) These data have been used in previous studies. [15–17] The Staff Model HMO contracted with area hospitals for inpatient services. For hospitalization and other outside utilization, the HMO maintains claims data using ICD-9 codes; this data structure contains up to six diagnoses and up to 3 surgical procedures per claim.
Group model HMO
The Group Model division of HPHC included 16 medical groups in 1993 that contracted with the HMO on a non-exclusive basis, i.e. they were exclusive with regard to other managed care plans, but not with respect to indemnity insurance. Most were primary care groups but a small number were multispecialty groups. Payment of groups was based on various forms of capitation; the most common arrangement was for groups to be capitated for both primary and specialty outpatient care, and for hospitalization risk to be shared in a wider pool. Capitation rates and details such as loss-limit provisions varied from group to group. Almost all groups comprised between 5 and 10 physicians.
Data from the Group Model were obtained from claims that were submitted to the HMO to document care for calculations pertinent to loss-limit provisions, even though payments were not based on the claims themselves. Data files contained information on services provided in the offices of the primary care clinicians, on outpatient services not provided by the primary care provider, (i.e. referrals), and on hospitalizations. Diagnoses and procedures were coded using ICD-9 and CPT-4 codes.
Demographic and insurance coverage information on members in the study were obtained from HMO enrollment files.
Medicare beneficiaries were included in this study if they were: age 65 and older as of January 1, 1994; had both Part A and B coverage for at least 12 consecutive months during 1994 and 1995; were not enrolled in an HMO during these 12 consecutive months; and resided within the HMO catchment area (see below).
We matched Medicare members enrolled in the HMO with those in fee-for-service by area of residence. First, we constructed a list of the zip codes in which eligible HMO members resided during the study period. We constructed a list of Medicare fee-for-service beneficiaries residing in the comparison area consisting of all contiguous zip codes in which at least one HMO Medicare beneficiary resided. The resulting sample included 339,627 people.
Data for the fee-for-service sample were obtained from an enrollment file for demographic information, the MedPAR (Medicare Provider Analysis and Review) file for hospitalization claim data, Part B physician/supplier claims file, and Hospital Outpatient Department claims file.
We developed performance measures that met several or all of the following criteria: the disease or condition was relatively common and potentially severe; a clinical service that could affect the health outcome of the patient was identifiable; the performance of the indicated service depended in part on the role of a physician or health system and not only on the patient; service performance was potentially subject to financial incentives; it was possible from other research to assume that the indicated service would on average improve outcome; and data to construct the indicator were currently or potentially available.
Our indicators assessed access to health care in three domains (Table 1): 1) preventive care, including services that provide future, not current, benefit; 2) diagnosis-specific care, examining treatment for acute conditions or episodes of disease; and 3) chronic disease care, including secondary prevention. The selection of preventive care indicators was guided by the generic applicability of these maneuvers in this age group, making it unnecessary to define a special population for whom the procedure would be indicated. The indicators of timely follow-up after hospitalization (diagnosis-specific care) were selected based on the seriousness of the medical conditions;  the time interval between hospital discharge and outpatient visit were determined by a panel of physicians.
A panel of national experts in access to quality health care, convened by the Health Care Financing Administration in March of 1996, suggested additions to our original indicator set. We then selected those that best met the structured evaluation criteria, including at least two indicators in each of the domains. Table 1 shows the indicators organized by domains. More complete definitions of inclusion criteria and coding, including specific AMRS, ICD-9 and CPT codes used, have been published elsewhere  and are summarized in Additional file Indicator Definitions.
We compared the three samples by age category using the chi-square test. For annual indicators, we averaged utilization rates for 1994 and 1995; the denominators were individuals eligible for each calendar year. We calculated rates in three age strata: age 65–74, 75–84, and 85 years and older. We also calculated age-adjusted rates standardized to the fee-for-service sample. Analyses were performed using SAS. We conducted two-way comparisons of age-adjusted rates across the three samples (Staff Model, Group Model, and fee-for-service) using the chi-square test.
Demographic characteristics of the study subjects are shown in Table 2. The FFS population in the region under study was older than the nationwide Medicare population, and a slightly larger proportion was female (62% versus 60%, p < 0.001). Those enrolled in the HMO were younger than both the geographically matched, fee-for-service sample and Medicare enrollees in the US as a whole (p < 0.001), and they were less likely to be female (p 0.001).
Age-adjusted rates of breast cancer screening with mammography were substantially higher in the two HMO settings than under fee-for-service insurance. (Table 3). Mammography screening rates in the Staff Model were nearly double those in the FFS sample. The proportion of Medicare enrollees who saw a clinician within a one-year period (Annual visit rate, Table 3) was greater than 85% in all three groups; however, this rate was significantly higher in the Staff Model HMO (94%) than the fee-for-service sample (88%)(p < 0.001).
Proportion with follow up by either a primary care physician or cardiologist within 60 days of hospital discharge after myocardial infarction (Table 4) was similar in the two managed care divisions and, in both cases, higher than under fee-for-service insurance (91% and 93% in the Staff and Group Model respectively, compared to 73% in FFS; p < 0.001). Follow up within 14 days after hospitalization for depression was highest in the Group Model HMO, although small sample size limited our ability to find statistically significant differences (p > 0.3).
Care of chronic diseases is summarized in Table 5. Screening rates for diabetic retinopathy were higher in both divisions of the managed care organization than in the fee-for-service sample. The proportion of diabetics with 2 or more visits was 50% higher in managed care than in fee-for-service (95% and 91% in the Staff and Group Model, respectively, versus 61% in FFS, p < 0.001).
We developed a set of indicators of access to effective care for elderly people insured by Medicare designed to fit varying clinical settings, insurance structures, and data systems. In general, performance in both the Staff and Group Model divisions of the managed care plan studied was equivalent to or better than that in the fee-for-service sector. Other investigators have devised administrative claims-based indicators, [21, 22] and chart review-based indicators for hospitals,  and ambulatory care sites,  in efforts to compare hospital performance or health plan performance. In contrast, we explored the feasibility of using data elements available in an automated outpatient medical record, which are increasingly prevalent, in addition to those available in claims databases. The indicators we selected overlap with those chosen to be included in the Health Plan Employer Data and Information Set (HEDIS) for the Medicare population, released in 1997, which also evaluates breast cancer screening and retinal screening for diabetics. 
Previous studies comparing performance indicators across insurance types have found inconsistent results. HMO performance on preventive services is consistently higher than in FFS settings. [26–28] On the other hand, some studies' findings have raised a concern that vulnerable populations such as the chronically ill  and the elderly  fare less well in HMOs than in FFS care. In the Medicare population, data to support concern about worse outcomes of care in HMOs has come from a national telephone survey about persistence of symptoms. 
In numerous other investigations, however, care for the Medicare population provided by HMOs has been shown to be comparable to that in FFS. No differences between HMO and FFS samples were found in studies of care for colon cancer, [31, 3, 2] breast cancer,[33, 34] prostate cancer, cardiovascular disease, rheumatoid arthritis, congestive heart failure,  hypertension,  acute myocardial infarction, acute appendicitis,  and stroke.  One study found that functional status did not decline faster among Medicare recipients enrolled in HMOs versus those in FFS.  Our findings are consonant with these previous studies: for example, a higher rate of mammography screening as seen in our managed care population could explain the trend to earlier stage breast cancers seen in California among HMO enrollees compared to FFS.,  While most of previous work focussed on specific disease entities, we studied the general Medicare population and measured indicators applicable to all enrollees, as well as indicators focussed on specific disease-populations.
There are few studies of the effect of managed care structure, (e.g. Group vs. Staff vs. IPA models) on indicators of quality care. [44, 45] These models differ both in the extent to which financial risk is attached to individual providers, and also the degree to which providers are effectively formed into an organized system of care. For example some of the differences seen in our study between the Group and Staff Model were probably due to organizational processes and systems in place in the Staff Model, such as physician reminder systems for preventive services leading to higher rates of breast cancer screening.
This study has several strengths. We included a large number of Medicare enrollees covered by the health plan studied, and the universe of fee-for-service Medicare enrollees in the same geographic region. Matching by region reduces the variation that may have affected some previous comparisons of FFS and HMO populations, in which national samples were used.  This method also automatically accounts for any "spillover" effect of managed care practices onto fee-for service practice, wherein cost-saving techniques are applied widely by providers, even to those with fee-for-service insurance, in a market with high penetration of managed care insurance.  In contrast to studies that focus on inpatient data (in part because of their ready availability,) our focus on outpatient care is highly relevant to comparisons of managed care with fee-for-service care in terms of ambulatory practices that may prevent hospitalizations. Our work on the time period 1994–95 follows the transformations in managed care in 1991–1993, and thus can been seen as an update to previous studies of the topic.
Our study also has limitations. People enrolling in managed care organizations may be systematically different from those choosing fee-for-service arrangements.  For example, patients who are sicker or more disabled may not enroll, or may differentially choose to leave managed care.  Those who do enroll could be more aggressive in seeking care. We know that a smaller proportion of HMO enrollees were over the age of 85 years, compared to the matched fee-for-service sample. Differential enrollment could influence our results if patients with higher degrees of co-morbid conditions preferentially enrolled in the fee-for service system and did not participate in cancer screening or secondary diabetic prevention because of their other illnesses.  In addition, the annual visit rate could potentially be overestimated in the HMO population if an influx of new patients and a "new enrollee" effect were to cause more patients to come in for visits than otherwise would. Another potentially important limitation is that different data systems created for different purposes, such as claims and clinical databases, may not provide comparable results, even for strictly defined indicators.[53, 54]
The use of performance indicators to compare care provided in different settings usually requires expensive data gathering. Indicators based on automated data systems offer partial relief to this problem. Our findings related to staff model and group model HMO types should be replicated in other settings, and extended to other types of managed care. While the staff model HMO share of the market is shrinking, group and network model health maintenance organizations are experiencing increased enrollment. Our finding of concordance on many indicators between the Group and Staff Model divisions suggests that a less tightly organized provider system may perform as well as a staff model HMO. Neither of the HMO divisions studied resembles an independent practice association (IPA) model, so our findings may not apply to that form of provider organization. In addition we studied only one managed care organization, one that is well established, and exists in a region of the country with high level access to specialty services. The generalizability of our findings to other managed care populations is unknown. Furthermore, the single HMO studied is a not-for profit organization, and our findings might not be applicable to for-profit entities. 
In conclusion, we believe that the indicators we have tested are feasible to implement in other managed care systems, and could be translated into other electronic medical record systems. Indicators such as these might be useful for consumers in comparing health plans to one another, such as those participating in Medicare+Choice. We found no evidence of any decrement in access to health care for the elderly Medicare population enrolled in one managed care plan in this geographic region. The low- or no cost "supplemental" insurance provided by many HMOs may in fact lower financial barriers to care for low-income seniors. Our study describes only two models of managed care, and this is a crude classification by current standards. Yet to be studied are the effects of financial incentives on increasingly smaller units of leverage, e.g. small IPA model groups, and the effectiveness of managed care plans that use sophisticated information systems to track and improve care, as compared to those that use principally financial incentives. [56, 57] The latter is crucial to understanding how best to create a partnership between providers and health plans that facilitates the provision of excellent care.
Bazos DA, Fisher ES: Capitation among Medicare beneficiaries. Effective Clinical Practice. 1999, 2: 24-29.
Dudley RA, Luft HS: Managed care in transition. N Engl J Med. 2001, 344: 1087-1092. 10.1056/NEJM200104053441410.
Hillman AL: Financial incentives for physicians in HMOs. N Engl J Med. 1987, 317: 1743-1748.
Relman AS: Dealing with conflicts. N Engl J Med. 1987, 313: 749-751.
Reagan MD: Physicians as gatekeepers, a complex challenge. N Engl J Med. 1987, 317: 1731-1734.
Aston G: Patient protections follow party lines. American Medical News. 5-6. April 5, 1999
Zwillich T: Senate approves "Patients Bill of Rights". Yahoo News. 7-2-2001, [http://dailynews.yahoo.com/h/nm/20010702/hl/senate_rights_l.html]
Robinson JC: Blended payment methods in physician organizations under managed care. JAMA. 1999, 282: 1258-1263. 10.1001/jama.282.13.1258.
Eddy DM: Balancing cost and quality in fee-for-service versus managed care. Health Aff. 1997, 16: 162-173. 10.1377/hlthaff.16.3.162.
Landon BE, Wilson IB, Cleary PD: A conceptual model of the effects of health care organizations on the quality of medical care. JAMA. 1998, 279: 1377-1382. 10.1001/jama.279.17.1377.
Gold MR, Hurley R, Lake T, Ensor T, Berenson R: A national survey of the arrangements managed-care plans make with physicians. N Engl J Med. 1995, 333: 1678-1683. 10.1056/NEJM199512213332505.
Gold M: Financial incentives; current realities and challenges for physicians. J Gen Intern Med. 1999, 14 Supplement 1: S6-S12. 10.1046/j.1525-1497.1999.00260.x.
Miller RH, Luft HS: Does managed care lead to better or worse quality of care?. Health Aff. 1997, 16: 7-23. 10.1377/hlthaff.16.5.7.
Barnett GO, Justice N, Somand M: COSTAR: A computer based medical information system for ambulatory care. Proc IEEE. 1979, 67: 1226-1237.
Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R: Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997, 277: 887-891. 10.1001/jama.277.11.887.
Heckbert SR, Stryker WS, Coltin KL, Manson JE, Platt R: Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol. 1990, 132: 336-342.
Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med. 1995, 155: 1605-1609. 10.1001/archinte.155.15.1605.
Moy E, Hogan C: Access to needed follow-up services. Arch Intern Med. 1993, 153: 1815-1823. 10.1001/archinte.153.15.1815.
Dayhoff DA, Rosenbach M, Walsh E, Barton MB, Fletcher RH, Soumerai SB: Measuring performance in managed care plans. Final report under contract number HCFA-500-95-0048-0002. Prepared for the Health Care Financing Administration. Waltham, MA, Health Economics Research, Inc. 1998
SAS Institute Inc.. SAS. 6.10. Cary, N.C., SAS Institute Inc. 1996
Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer RH: Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA. 1995, 273: 1503-1508. 10.1001/jama.273.19.1503.
Physician Payment Review Commission. Monitoring Access of Medicare Beneficiaries. Washington, DC. 1995, 95-1.
Kazandjian VA, Lawthers J, Cernak CM, Pipesh Fc: Relating outcomes to processes of care: The Maryland Hospital Association's Quality Indicator Project (QI Project). Jt Comm J Qual Improv. 1993, 19: 530-538.
Lawthers AG, Palmer RH, Edwards JE, Fowles J, Garnick DW, Weiner JP: Developing and evaluating performance measures for ambulatory care quality: a preliminary report of the DEMPAQ Project. Jt Comm J Qual Improv. 1993, 19: 552-565.
Health Plan Employer Data and Information Set (HEDIS) 3.0. Washington, DC, National Committee for Quality Assurance. 1997
Retchin SM, Brown B: The quality of ambulatory care in Medicare health maintenance organizations. Am J Public Health. 1990, 80: 411-415.
Gordon NP, Rundall TG, Parker L: Type of health care coverage and the likelihood of being screened for cancer. Med Care. 1998, 36: 636-645. 10.1097/00005650-199805000-00004.
Eppig FJ, Poisal JA: Medicare FFS populations versus HMO populations: 1993. Health Care Financ Rev. 1996, 17: 263-267.
Clement DG, Retchin SM, Brown RS, Stegall MH: Access and outcomes of elderly patients enrolled in managed care. JAMA. 1994, 271: 1487-1492. 10.1001/jama.271.19.1487.
Ware JE, Brook RH, Rogers WH, Keeler EB, Davies AR, Sherbourne CD, et al: Comparison of health outcomes at a health maintenance organisation with those of fee-for-service care. Lancet. 1986, 1017-1022. 10.1016/S0140-6736(86)91282-1.
Retchin SM, Penberthy L, Desch C, Brown R, Jerome-D'Emilia B, Clement D: Perioperative management of colon cancer under Medicare risk programs. Arch Intern Med. 1997, 157: 1878-1884. 10.1001/archinte.157.16.1878.
Vernon S, Hughes JI, Heckel VM, Jackson GL: Quality of care for colorectal cancer in a fee-for-service and health maintenance organization practice. Cancer. 1992, 69: 2418-2425.
Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G: Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisions. J Gen Intern Med. 2001, 16: 189-199. 10.1046/j.1525-1497.2001.91112.x.
Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R: Stage at diagnosis and treatment patterns among older women with breast cancer. JAMA. 1999, 281: 720-726. 10.1001/jama.281.8.720.
Potosky AL, Merrill RM, Riley GF, Taplin SH, Barlow W, Fireman BH, et al: Prostate cancer treatment & ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res. 1999, 34: 525-546.
Seidman JJ, Bass EP, Rubin HR: Review of studies that compare the quality of cardiovascular care in HMO versus non-HMO settings. Med Care. 1998, 36: 1607-1625. 10.1097/00005650-199812000-00001.
Yelin EH, Shearn MA, Epstein WV: Health outcomes for a chronic disease in prepaid group practice and fee for service settings. Med Care. 1986, 24: 236-247.
Retchin SM, Brown B: Elderly patients with congestive heart failure under prepaid care. Am J Med. 1991, 90: 236-242.
Preston JA, Retchin SM: The management of geriatric hypertension in health maintenance organizations. J Am Geriatr Soc. 1991, 39: 683-690.
Soumerai SB, McLaughlin TJ, Gurwitz JH, Pearson S, Christiansen C, Borbas C, et al: Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance. Arch Intern Med. 1999, 159: 2013-2020. 10.1001/archinte.159.17.2013.
Braveman P, Schaaf VM, Egerter S, Bennett T, Schecter W: Insurance-related differences in the risk of ruptured appendix. N Engl J Med. 1994, 331: 444-449. 10.1056/NEJM199408183310706.
Retchin SM, Brown RS, Yeh SJ, Chu D, Moreno L: Outcomes of stroke patients in Medicare fee for service and managed care. JAMA. 1997, 278: 119-124. 10.1001/jama.278.2.119.
Porell FW, Miltiades HB: Disability outcomes of older Medicare HMO enrollees and fee-for-service Medicare beneficiaries. J Am Geriatr Soc. 2001, 49: 615-631. 10.1046/j.1532-5415.2001.49123.x.
Safran DG, Rogers WH, Tarlov AR, Inui TS, Taira DA, Montgomery JE, et al: Organizational & financial characteristics of health plans: are they related to primary care performance?. Arch Intern Med. 2000, 160: 69-76. 10.1001/archinte.160.1.69.
Meredith LS, Rubenstein LV, Rost K, Ford DE, Gordon N, Nutting P, et al: Treating depression in staff-model versus network-model managed care organizations. J Gen. Intern Med. 1999, 14: 39-48. 10.1046/j.1525-1497.1999.00279.x.
Carlisle DM, Siu AL, Keeler EB, McGlynn EA, Kahn KL, Rubenstein LV, et al: HMO vs fee-for-service care of older persons with acutemyocardial infarction. Am J Public Health. 1992, 82: 1626-1630.
Baker LC: Association of managed care market share and health expenditures for fee-for-service Medicare patients. JAMA. 1999, 281: 432-437. 10.1001/jama.281.5.432.
Dans PE: Looking for answers in all the wrong places. Ann Intern Med. 1993, 119: 855-857.
Welch WP, Welch HG: Fee-for-data: A strategy to open the HMO black box. Health Aff. 1995, 14: 104-116. 10.1377/hlthaff.14.4.104.
Riley G, Tudor C, Chiang Y, Ingber M: Health status of Medicare enrollees in HMOs and fee-for-service in 1994. Health Care Financ Rev. 1996, 17: 65-76.
Morgan RO, Virnig BA, DeVito CA, Persily NA: The Medicare-HMO revolving door – the healthy go in and the sick go out. N Engl J Med. 1997, 337: 169-175. 10.1056/NEJM199707173370306.
Kiefe CI, Funkhouser E, Fouad MN, May DS: Chronic disease as a barrier to breast and cervical cancer screening. J Gen. Intern Med. 1998, 13: 357-365. 10.1046/j.1525-1497.1998.00115.x.
Stange KC, Zyzanski SJ, Smith TF, Kelly R, Langa DM, Flocke SA, et al: How valid are medical records and patient questionnaires for physician profiling and health services research?. Med Care. 1998, 36: 851-867. 10.1097/00005650-199806000-00009.
Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB: Discordance of databases designed for claims payment versus clinical information systems. Ann Intern Med. 1993, 119: 844-850.
Himmelstein DU, Woolhandler S, Hellander I, Wolfe SM: Quality of care in investor-owned vs not-for-profit HMOs. JAMA. 1999, 282: 159-163. 10.1001/jama.282.2.159.
Wong HS, Hellinger FJ: Conducting research on the Medicare market: the need for better data and methods. Health Serv Res. 2001, 36: 291-308.
Hellinger FJ: The effect of managed care on quality. Arch Intern Med. 1998, 158: 833-841. 10.1001/archinte.158.8.833.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/1/11/prepub
We would like to acknowledge Ernest Shtatland and Nora Rudenko for their valuable programming assistance, and Renee Mentnech, PhD for guidance and advice.
Support: This study was supported by Contract Number 500-95-0048 sponsored by the Health Care Financing Administration, Department of Health and Human Services, and by the Thomas O. Pyle Fellowship of the Harvard Pilgrim Health Care Foundation.